BioPerfectus
Biotechnology Empowers the Perfection of Human Life

Jiangsu Bioperfectus Technologies Co., Ltd.

(SSE:688399)

BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers specialized in infectious diseases ever since 2010. With headquarter located in Jiangsu, subsidiaries in Shanghai, Beijing, Xi’an, Taizhou, Hainan and Yinchuan. Bioperfectus is pioneering in molecular diagnostics market with our products ranging from real time PCR kits, nucleic acid extraction systems, rapid tests and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream to create a healthier future for our next generations.

62,000+㎡

An industrial park of over 62,000㎡ integrating fully self-innovative R&D, production, warehousing, logistics, sales, marketing and customer service divisions catering for various business scenarios

600+

Over 600 Bioperfectus people’s permission gathering the perseverance and determination to fight against the global pandemic

5,000,000+

Production capacity ramping up to more than 5 million tests/day ensuring the quick sufficient response to infectious diseases

global presence

80 Countries within a year

Bioperfectus Products & Service have been distributed to over 80+ countries around the globe within only one year since the international business established.

10000 Machinery spots

Bioperfectus Nucleic Acid Extraction Solutions 
were launched in over 10,000 laboratories 
globally with a well-trained and quick-response 
customer service team.

News Center
12-022021
Declaration on the Effectiveness of Bioperfectus SARS-CoV-2 Antigen Rapid Test Kit against New Variant Omicron
Declaration on the Effectiveness of Bioperfectus SARS-CoV-2 Antigen Rapid Test Kit against New Variant Omicron
12-022021
The spread of the new variant Omicron is faster than expected. The countries and regions with reported Omicron cases on the GISAID website have been increased to twenty-one on Dec. 2, 2021. The data only showed the number of submitted sequenced cases, which might be just the tip of the iceberg. Source: https://www.gisaid.org/hcov19-variants/ Facing this more contagious variant, not only our real-time PCR kits but also our antigen rapid test kit stay reliable and effective. After an...
12-022021
Registration Updates: Bioperfectus SARS-CoV-2 Antigen Rapid Test was Approved by the Ministry of Health Israel
Registration Updates: Bioperfectus SARS-CoV-2 Antigen Rapid Test was Approved by the Ministry of Health Israel
12-022021
Bioperfectus is proud to announce thatNovel Corona Virus (SARS-CoV-2) Ag Rapid Testwas approved by the Ministry of Health Israel. Registration information is now available on the Ministry of Health Israel website, clickhere to learn more
12-012021
End Inequalities, End AIDS
End Inequalities, End AIDS
12-012021
HIV (human immunodeficiency virus)is a virus that attacks cells that help the body fight infection, making a person more vulnerable to other infections and diseases. It is spread by contact with certain bodily fluids of a person with HIV, most commonly during unprotected sex (sex without a condom or HIV medicine to prevent or treat HIV), or through sharing injection drug equipment.If left untreated, HIV can lead to the disease AIDS (acquired immunodeficiency syndrome). The human body cant ge...
Service Network
Support is only one step away
A good after-sales service is essential for efficiency of workload in PCR laboratory. Bioperfectus delivers most perfect service via our authorized distributors and global service center. With well-experienced service staff, sufficient spare-part inventory and fast global logistics, Bioperfectus aims to provide with the satisfactory solutions to our end users.We offer 24/7 after-sales service, prompt response and periodical training programs.
CONTACT US NOW